5-hydroxymethylcytosine has been researched along with Lymphoma, B-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carll, TC; Chiu, BC; Kline, J; Riedell, P; Smith, S; Tanager, KS; Tatarian, AH; Venkataraman, G; Yu, J | 1 |
| Hirota, S; Imai, Y; Matsuda, I | 1 |
| Aifantis, I; Aranda-Orgilles, B; Bakogianni, S; Bhattacharyya, S; Cimmino, L; Dawlaty, MM; Geng, H; Jaenisch, R; King, B; Liu, C; Lobry, C; Mullenders, J; Ndiaye-Lobry, D; Shaknovich, R; Shen, S; Trimarchi, T; Verma, AK; Yap, YS; Yu, Y | 1 |
3 other study(ies) available for 5-hydroxymethylcytosine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.
Topics: 5-Methylcytosine; Epigenesis, Genetic; Humans; Lymphoma, B-Cell; Mutation | 2022 |
Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Humans; Immunohistochemistry; Lymphoma, B-Cell; Male; Middle Aged; Young Adult | 2014 |
TET1 is a tumor suppressor of hematopoietic malignancy.
Topics: 5-Methylcytosine; Animals; B-Lymphocytes; Cell Differentiation; Cell Lineage; Chromosomal Instability; Cytosine; DNA Methylation; DNA Repair; DNA-Binding Proteins; Embryonic Stem Cells; Epigenesis, Genetic; Exome; Gene Expression Profiling; Humans; Lymphoma, B-Cell; Mice; Mutation; Proto-Oncogene Proteins; Tumor Suppressor Proteins | 2015 |